CMS signals intent to revamp how it pays for clinical software and AI

July 16, 2026 - 12:48

The Centers for Medicare and Medicaid Services has announced plans to overhaul how it reimburses healthcare providers for clinical software and artificial intelligence tools. The agency intends to build a standardized payment structure that moves away from the current patchwork of codes and billing rules. Instead, CMS wants to tie reimbursement directly to how these technologies affect patient outcomes.

Under the proposed framework, payment levels would vary based on the demonstrated clinical value of a given software or AI application. Tools that show measurable improvements in diagnosis accuracy, treatment success, or patient safety could qualify for higher reimbursement rates. The goal is to encourage developers to focus on real-world effectiveness rather than just feature counts or marketing claims.

Industry observers note that this shift could reshape the market for digital health tools. Currently, many AI algorithms and clinical decision support systems are billed under vague or outdated codes, making it hard for hospitals to justify their cost. A standardized system based on outcomes would create clearer incentives for adoption. However, questions remain about how CMS will measure outcomes across different specialties and settings. The agency has not yet released a timeline for final rules, but it has signaled that public comment will be sought before any changes take effect.